Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...
Chemical synthesis and peptide ligation techniques have revolutionised the field of protein engineering by enabling the precise construction of peptides and proteins with tailored modifications. These ...
Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...
Hosted on MSN
First-ever ribosomal synthesis of cyclic peptides opens new avenues for next-generation drug design
Inside our cells, ribosomes—the tireless "protein factories" of life—have just shown off a new skill they haven't used in billions of years. A research team has become the first in the world to ...
Argobio Studio, the launch platform for Europe's best innovative science, today announced the successful seed financing of Enodia Therapeutics, a ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...
PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...
Medical Device Network on MSN
Enodia raises seed funding to advance protein degradation platform
Enodia Therapeutics has raised €20.7m ($25m) in seed funding to advance a small-molecule platform for targeted protein ...
Barcoding technologies using the high information content encoded in oligonucleotide sequences have aided various applications in biotechnology, especially when paired with next-generation DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback